Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 18, 2024 14:08 ET | Source: CVRx, Inc.

CVRx announces new CPT® Category I codes for Barostim

MINNEAPOLIS, Oct. 18, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the American Medical Association (AMA) CPT®...
October 15, 2024 16:30 ET | Source: CVRx, Inc.

CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024

MINNEAPOLIS, Oct. 15, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an...
September 12, 2024 08:00 ET | Source: CVRx, Inc.

CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim

New data published in JACC: Heart Failure demonstrate durable benefits in MLWHF and EQ-5D quality of life measures in heart failure patients with reduced ejection fraction MINNEAPOLIS, Sept. 12,...
September 03, 2024 08:30 ET | Source: CVRx, Inc.

CVRx Announces Appointment of Two New Board Members

MINNEAPOLIS, Sept. 03, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced the appointments of Kevin Ballinger and Mitch Hill to...
August 02, 2024 08:00 ET | Source: CVRx, Inc.

CVRx Announces Increased Inpatient Payment for Barostim Procedure

MINNEAPOLIS, Aug. 02, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that Centers for Medicare and Medicaid Services (CMS)...
July 31, 2024 16:27 ET | Source: CVRx, Inc.

CVRx to Present at the Canaccord Genuity 44th Annual Growth Conference

MINNEAPOLIS, July 31, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the Canaccord...
July 29, 2024 16:05 ET | Source: CVRx, Inc.

CVRx Reports Second Quarter 2024 Financial and Operating Results

MINNEAPOLIS, July 29, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
July 15, 2024 16:30 ET | Source: CVRx, Inc.

CVRx to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call on July 29th, 2024

MINNEAPOLIS, July 15, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an...
June 25, 2024 06:50 ET | Source: CVRx, Inc.

CVRx Announces Appointment of Robert Allen John as Chief Revenue Officer

MINNEAPOLIS, June 25, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced the appointment of Robert John as Chief Revenue Officer...
May 22, 2024 08:30 ET | Source: CVRx, Inc.

CVRx to Present at the William Blair 44th Annual Growth Stock Conference

MINNEAPOLIS, May 22, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the William...